MPM BioVentures 2014 (B), L.P. Plans to Sell Common Shares of Werewolf Therapeutics, Inc.

MPM BioVentures 2014 (B), L.P. has filed a notice indicating its intention to sell 8,679 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The sale is planned to occur on or around October 27, 2025, with Merrill Lynch acting as the broker. The aggregate market value of the shares to be sold is approximately $15,361.83. MPM BioVentures 2014 (B), L.P. has reported no transactions in the past three months. The filing was signed by Kristen Laguerre on October 27, 2025, and the plan was adopted on September 24, 2025.